Evidence map›Paper›PMID 42760417›Full record

ArticleMolecular genetics and genomics : MGG2026

Codon optimality predicts mRNA half-life but does not transfer to lncRNAs.

Hidenori Tani

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hidenori TaniDepartment of Health Pharmacy, Yokohama University of Pharmacy, Yokohama, Japan. hidenori.tani@yok.hamayaku.ac.jp.ORCID https://orcid.org/0000-0001-6390-4136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Codon optimality couples translation elongation to decay and is among the strongest reported sequence determinants of mRNA half-life. Long non-coding RNAs (lncRNAs) are largely untranslated. Is lncRNA stability sequence-encoded in the way mRNA stability is? We compared the classes on half-lives from the same assays, re-estimating the codon stabilization coefficient (CSC) inside each cross-validation fold to remove label leakage. Performance is the cross-validated coefficient of determination R² - 1 for perfect prediction, 0 for the training mean, negative for worse - and the Spearman rank correlation ρ between predicted and measured half-life. mRNA half-life was sequence-predictable (R² = 0.174, ρ = 0.44), and CSC alone (R² = 0.084) outperformed a six-member translation-independent set (R² = 0.008), an ordering that held in three further datasets, two assays and two species. lncRNA half-life was not: R² = -0.050 in same-assay HeLa lncRNAs (n = 364) and R² = +0.0007 from k-mer composition in the largest published lncRNA dataset (n = 33,285), where that study's own cross-validated ρ is 0.091. That value clears its permutation null: the classes differ in magnitude, not detectability. Pretrained genomic language models, one covering 99.6% of transcripts whole, left mRNAs at R² = 0.042 and lncRNAs at 0.0002-0.0036. Coding-potential strata change nothing; matching on length, GC and n with an identical feature set gives R² = 0.033 versus 0.0002. Signal injection puts the reliable detection limit near 0.5% of variance, above every lncRNA value obtained. mRNA-derived decay models should not be transferred to lncRNAs without re-validation.

Indexed as

CodonRNA, Long NoncodingRNA, MessengerRNA StabilityHalf-LifeHeLa CellsHumansCodonRNA, Long NoncodingRNA, MessengerCodon optimalityCross-validationlncRNAMachine learningmRNA stabilityRNA half-life

Identifiers

PMID42760417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.